Key facts
- This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 31 May 2022, 18:15.
Birgit Girshick - 27 May 2022 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- Corporate Executive VP & COO
- Issuer ticker
- CRL
- Reported as of
- 27 May 2022
- Net transaction value
- +$1,531,473
- SEC form
- 4
- Accepted by SEC
- 31 May 2022, 18:15:32 UTC
- Prior SEC filing
- 23 Feb 2022
- Next SEC filing
- 30 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Birgit Girshick
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 31 May 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: +$1,531,473.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,455
- Change %
- +7.3%
- Price
- $0.000000
- Shares after
- 36,124
- Date
- 27 May 2022
- Ownership
- Direct
- Footnotes
- F1
CRL
transaction
Common Stock
Tax liability
- Transaction value
- $36,662
- Shares
- -150
- Change %
- -0.42%
- Price
- $244.41
- Shares after
- 35,974
- Date
- 28 May 2022
- Ownership
- Direct
CRL
transaction
Common Stock
Tax liability
- Transaction value
- $53,281
- Shares
- -218
- Change %
- -0.61%
- Price
- $244.41
- Shares after
- 35,756
- Date
- 29 May 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $1,621,416
- Shares
- +6,634
- Change %
- Price
- $244.41
- Shares after
- 6,634
- Date
- 27 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,634
- Exercise price
- $244.41
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Unvested restricted stock units vest as follows: 613 on May 27, 2023, 614 on May 27, 2024, 614 on May 27, 2025 and 614 on May 27, 2026.
Footnote F2
Stock Options vest as follows: 1,658 on May 27, 2023, 1,659 on May 27, 2024, 1,658 on May 27, 2025 and 1,659 on May 27, 2026.